HCC Q1 FY27: consolidated PAT flat at ₹51 Cr as revenue falls 9%, margins compress
PAT +0.69% YoY · revenue -8.97% · margins compressing
₹993.42 Cr
-8.97% YoY
₹51.08 Cr
+0.69% YoY
4.84%
+0.3pp YoY
₹0.19
HCC's consolidated PAT for Q1 FY27 came in at ₹51.08 Cr, up a marginal 0.7% YoY from ₹50.73 Cr and down 13.3% QoQ from ₹58.94 Cr, on consolidated revenue of ₹993.42 Cr that fell 9.0% YoY from ₹1,091.33 Cr (broadly flat QoQ, +0.1%). Standalone, the core E&C business posted revenue of ₹981.73 Cr (down 8.2% YoY) and PAT of ₹37.08 Cr (down 3.9% YoY from ₹38.58 Cr) — a weaker trajectory than the consolidated print, the gap explained by a ₹0.48 Cr JV profit share and other-income differences at the group level. No brokerage consensus estimates for the quarter's revenue or PAT could be located, so the print cannot be benchmarked against street numbers this quarter.
Q1 FY-2027 vs prior quarters
The flat headline PAT masks a sharp compression in core profitability: consolidated operating margin fell to 10.58% from 16.45% a year ago and 17.79% in Q4 FY26, driven by a heavier subcontracting-cost mix (₹567.04 Cr, 57.1% of revenue, vs ₹600.32 Cr/55.0% YoY) on a smaller revenue base; standalone EBITDA margin similarly nearly halved to 10.7% from 14.9% YoY per the company's own release. What held net profit up was other income, which more than doubled to ₹62.08 Cr from ₹27.33 Cr YoY (versus ₹25.31 Cr in Q4 FY26) — without that jump, pre-tax profit growth of 1.5% YoY to ₹74.40 Cr would instead have been a steep decline. Net margin still edged up to 5.14% from 4.65% YoY on this non-operating boost. EPS nonetheless fell to ₹0.19 from ₹0.25 YoY despite the flat PAT, because paid-up equity capital rose 44% YoY to ₹261.95 Cr from ₹181.94 Cr on prior-year share issuance — a dilution effect the headline profit figure doesn't show.
The stock went into the print at ₹21.55, down 5.5% over the past month of trading.
Management has issued aggressive guidance for FY27, targeting an order intake of ₹15,000 crore, which is expected to increase the order backlog to between ₹24,000-₹27,000 crore by year-end. While no specific revenue guidance was provided, the company expects healthy growth and a long-term CAGR of 20-25%, while maintain
Management gave no specific FY27 revenue guidance on the Q4 FY26 call, instead targeting ₹15,000 Cr of order intake to lift the backlog to ₹24,000-27,000 Cr by year-end, a 20-25% long-term revenue CAGR, 14-15% long-term EBITDA margins, and a debt-free balance sheet by FY28. One quarter in, order-booking pace looks slow against the ₹15,000 Cr target: HCC won just ₹125 Cr of new orders and emerged L1 on ₹2,124 Cr of projects (its own share ₹1,671 Cr), with ₹9,997 Cr of bids still under evaluation — the bulk of the annual target still needs to be booked or converted from L1 status. This quarter's 10.58% operating margin also sits well below the 14-15% long-term target. Deleveraging progress is real, though: consolidated debt-equity fell to 0.46x from 1.64x a year ago as net worth rose to ₹2,137.31 Cr from ₹1,003.90 Cr, consistent with the FY28 debt-free goal. Execution stayed on track across the portfolio — HRT breakthroughs at Tapovan Vishnugad, 85% HRT excavation at Vishnugad Pipalkoti, TBM deployment starting at Indore Metro, and delivery of Rajasthan Atomic Power Project Units 7 & 8 in the nuclear vertical — none of which yet shows up as a step-change in revenue. Total work-on-hand stood at ₹12,976 Cr as of June 30, 2026, barely up from ₹12,971 Cr at March-end.
W1
Order-intake pace toward the ₹15,000 Cr FY27 target — only ₹125 Cr firm bookings in Q1; watch conversion of the ₹1,671 Cr HCC-share L1 wins and ₹9,997 Cr bids under evaluation
W2
Operating margin recovery toward management's 14-15% long-term EBITDA target from the current 10.58% consolidated margin (16.45% a year ago)
W3
Continued deleveraging toward the FY28 debt-free goal — consolidated debt-equity at 0.46x this quarter, down from 1.64x YoY